NCT05866185

Brief Summary

The purpose of this study is to expand Adhere.ly- a simple, HIPAA-compliant, web-based platform to help therapists engage clients in practicing therapeutic skills between sessions (homework) during mental health treatment by conducting a trial comparing standard therapy to therapy enhanced with Adhere.ly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 19, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2024

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

January 15, 2026

Completed
Last Updated

January 15, 2026

Status Verified

December 1, 2025

Enrollment Period

1.7 years

First QC Date

May 10, 2023

Results QC Date

May 22, 2025

Last Update Submit

December 19, 2025

Conditions

Keywords

mhealthmental healthadult mental healthhomeworkhealth technology

Outcome Measures

Primary Outcomes (2)

  • Generalized Anxiety Disorder-7 (Gad-7)

    The Generalized Anxiety Disorder Scale-7 (GAD-7) assesses the severity of anxiety symptoms in adults. The GAD-7 was completed by clients about themselves. Scores range from 0 to 21 with higher scores indicating worse anxiety symptom severity. A score of 8 or greater is generally considered to indicate clinically significant anxiety symptom severity.

    Baseline, 3 Months Post Baseline

  • Patient Health Questionnaire-8 (PHQ-8)

    The Patient Health Questionnaire-8 (PHQ-8) assesses the severity of depression symptoms in adults. The PHQ-8 was completed by clients about themselves. Scores range from 0 to 28 with higher scores indicating worse depression symptom severity. A score of 10 or greater is generally considered to indicate clinically significant depression symptom severity.

    Baseline, 3 Months Post Baseline

Secondary Outcomes (8)

  • Health-Related Quality of Life (HRQOL-14) - Healthy Mental Health Days Index

    Baseline, 3 Months Post Baseline

  • Homework Rating Scale II (HRS II)

    Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Average across weeks reported.

  • Assessment of Core CBT Skills (ACCS) - Cognitive Behavioral Therapy Domain

    Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8, Week 9, Week 10, Week 11, Week 12, Average across weeks reported.

  • Attitudes Toward Homework Questionnaire (ATHQ) - Positive Homework Effect Scale

    Baseline, Post-Trial Therapist Assessment

  • Working Alliance Inventory - Short Revised (WAI-SR)

    3 Months Post Baseline

  • +3 more secondary outcomes

Study Arms (2)

Therapy

ACTIVE COMPARATOR

Standard regular therapy.

Behavioral: Therapy

Therapy + Adhere.ly

EXPERIMENTAL

Standard regular therapy, enhanced with Adhere.ly

Behavioral: Therapy + Adhere.ly

Interventions

TherapyBEHAVIORAL

The standard of care procedures for adults with clinically elevated anxiety and/or depression from their mental health provider.

Therapy

Participants receive therapy as usual enhanced with a simple, HIPAA-compliant, web-based application to help mental health providers implement homework during therapy for adults with elevated anxiety and/or depression. The three major components of the app help providers to (1) Practice interactive, digitized therapeutic exercises with patients in-session; (2) Remind patients to practice exercises for homework, and (3) Review homework during the next session.

Therapy + Adhere.ly

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Providers:
  • English-speaking
  • Mental health providers who have obtained at least a master's degree in social work, counseling, clinical psychology, or related field
  • Carry active mental health treatment caseloads in the U.S.
  • Have a laptop, tablet, or smartphone with internet access
  • Clients:
  • English-speaking
  • Treatment-seeking adults ≥18 years
  • Clinically elevated anxiety and depression as indicated by a score ≥10 on the GAD-7 and/or PHQ-8
  • Have a laptop, tablet, or smartphone with internet access

You may not qualify if:

  • Client with self-reported:
  • Active psychotic symptoms (e.g., hallucinations, delusions)
  • Significant cognitive disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Florida

Tampa, Florida, 33613, United States

Location

MeSH Terms

Conditions

Anxiety DisordersDepressionPsychological Well-Being

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorPersonal Satisfaction

Results Point of Contact

Title
Brian Bunnell
Organization
University of South Florida

Study Officials

  • Brian E Bunnell, PhD

    University of South Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2023

First Posted

May 19, 2023

Study Start

September 1, 2022

Primary Completion

May 29, 2024

Study Completion

May 29, 2024

Last Updated

January 15, 2026

Results First Posted

January 15, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations